Odunsi K - Search Results

1

Anthropometric characteristics and ovarian cancer risk and survival.

Minlikeeva AN, Moysich KB, Mayor PC, Etter JL, Cannioto RA, Ness RB, Starbuck K, Edwards RP, Segal BH, Lele S, Odunsi K, Diergaarde B, Modugno F. Minlikeeva AN, et al. Among authors: odunsi k. Cancer Causes Control. 2018 Feb;29(2):201-212. doi: 10.1007/s10552-017-0997-5. Epub 2018 Jan 11. Cancer Causes Control. 2018. PMID: 29327114 Free PMC article.

2

Human ovarian cancer, lymphoma spleen, and bovine milk GlcNAc:beta1,4Gal/GalNAc transferases: two molecular species in ovarian tumor and induction of GalNAcbeta1,4Glc synthesis by alpha-lactalbumin.

Chandrasekaran EV, Chawda R, Piskorz C, Locke RD, Ta A, Sharad G, Odunsi K, Lele S, Matta KL. Chandrasekaran EV, et al. Among authors: odunsi k. Carbohydr Res. 2001 Aug 23;334(2):105-18. doi: 10.1016/s0008-6215(01)00150-1. Carbohydr Res. 2001. PMID: 11502266

3

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL. Odunsi KO, et al. Eur J Gynaecol Oncol. 2001;22(5):325-30. Eur J Gynaecol Oncol. 2001. PMID: 11766731

4

Evaluation of beta1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer.

Odunsi K, Ghamande S, Chandrasekaran EV, Ta A, Moysich KB, Driscoll D, Matta K, Lele S. Odunsi K, et al. Am J Obstet Gynecol. 2002 Sep;187(3):575-80. doi: 10.1067/mob.2002.125888. Am J Obstet Gynecol. 2002. PMID: 12237630

5

Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer.

Ghamande S, Lele S, Marchetti D, Baker T, Odunsi K. Ghamande S, et al. Among authors: odunsi k. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):142-7. doi: 10.1046/j.1525-1438.2003.13045.x. Int J Gynecol Cancer. 2003. PMID: 12657114 Clinical Trial.

6

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Odunsi K, et al. Cancer Res. 2003 Sep 15;63(18):6076-83. Cancer Res. 2003. PMID: 14522938

7

Clinicopathologic outcomes of laser conization for high-grade cervical dysplasia.

dos Santos L, Odunsi K, Lele S. dos Santos L, et al. Among authors: odunsi k. Eur J Gynaecol Oncol. 2004;25(3):305-7. Eur J Gynaecol Oncol. 2004. PMID: 15171305

8

Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.

Odunsi K, Moneke V, Tammela J, Ghamande S, Seago P, Driscoll D, Marchetti D, Baker T, Lele S. Odunsi K, et al. Int J Gynecol Cancer. 2004 Jul-Aug;14(4):659-64. doi: 10.1111/j.1048-891X.2004.14420.x. Int J Gynecol Cancer. 2004. PMID: 15304162

9

Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics.

Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL. Odunsi K, et al. Int J Cancer. 2005 Feb 20;113(5):782-8. doi: 10.1002/ijc.20651. Int J Cancer. 2005. PMID: 15499633

10

Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute.

Sharma S, Odunsi K, Driscoll D, Lele S. Sharma S, et al. Among authors: odunsi k. Int J Gynecol Cancer. 2005 May-Jun;15(3):475-82. doi: 10.1111/j.1525-1438.2005.15311.x. Int J Gynecol Cancer. 2005. PMID: 15882172 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters